This white paper outlines Polpharma B2B's finished dosage formulations (FDF) that are currently under development.

Products listed include Esomeprazole powder for the treatment of peptic ulcers and gastro-oesophageal reflux disease, Orlistat anti-obesity capsules, Sitagliptin film-coated tablets for reducing blood glucose, and the Aciclovir antiviral tablets for systemic use.

Download to find out more.